Article

Comprehensive Lung Cancer Screening at UC Davis

UC Davis CLSP is a multidisciplinary program for comprehensive lung cancer screening.

UC Davis Comprehensive Lung Cancer Screening Program

(CLSP)

UC Davis CLSP is a multidisciplinary program for comprehensive lung cancer screening. The innovative program provides low-dose chest computed tomography (LDCT) technology to detect lung cancer early in its most treatable form in those individuals at the highest risk for lung cancer. The groundbreaking National Lung Screening Trial (NLST) clearly shows that screening with LDCT scans reduces the risk of dying from lung cancer in heavy smokers by 20% compared to screening with simple chest X-rays. (N Engl J Med. 2011).

The UC Davis Comprehensive Lung Cancer Screening Program addresses the recent recommendations released on July 29, 2013 by the United States Preventive Services Task Force (USPSTF) for annual LDCT scans to screen individuals who are at high risk for lung cancer. To serve our patients in the program, we use a multidisciplinary team of Radiologists, Thoracic Surgeons, Pulmonologists, Pathologists, Medical Oncologists and Radiation Oncologists to develop a best-practice, patient-centered plan.

Who Do We Screen?

UC Davis CLSP serves a specific high-risk population for lung cancer. This population is defined by the results of the multi-institution NLST, the USPSTF recommendations and the National Comprehensive Cancer Network (NCCN) and includes the following:

a) High-Risk Patients: Group 1

i. Current or former smokers 50-80 years of age;

ii. Smoked the equivalent of one pack of cigarettes a day for at least 30 years;

iii. If a former smoker, he/she should have quit within the previous 15 years.

b) High-Risk Patients: Group 2

i. Current or former smokers 50-80 years of age;

ii. Smoked the equivalent of one pack of cigarettes a day for at least 20 years;

iii. Have one additional lung cancer risk factor. Risk factors include the following: personal lung cancer history (>5 years), family history of lung cancer (first degree relative), chronic lung disease, and carcinogen exposure (excluding second hand smoke exposure).

How do I Schedule an Exam?

We will need a referral from your Primary Care Provider or PCP

We would be happy to assist you with lung cancer screening or answer additional questions through our Radiology Department. Their phone number for scheduling is 916-734-0655. . The referral can be faxed to 916-703-2254.

Insurance does not currently pay for lung cancer screening, and an out-of-pocket price for the exam is $375.

The results will be reported back to your PCP. Should an abnormality be found which requires further evaluation; our UC Davis CLSP Practitioners, including Pulmonologists and/or Thoracic Surgeons, will assist you, if your PCP wishes to consult them.

In addition if interested, we can offer you advice and help on strategies to stop smoking.

Thank you again for choosing UC Davis CLSP!

Related Videos
Alec Watson, MD
Balazs Halmos, MD
Balazs Halmos, MD
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of pathologists in molecular testing in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of RNA and other testing considerations for detecting NRG1 and other fusions in solid tumors.
Mary B. Beasley, MD, discusses the prevalence of NRG1 fusions in non–small cell lung cancer and pancreatic cancer.